257 related articles for article (PubMed ID: 24144760)
21. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
Michielsen P; Roels L; Vanrenterghem Y; Boel A; van Damme B; Vermylen J
Clin Nephrol; 1976 Mar; 5(3):105-13. PubMed ID: 1261101
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure.
Okada K; Okawa E; Shibahara H; Maruyama T; Maruyama N; Matsumoto K; Takahashi S
Kidney Blood Press Res; 2004; 27(4):218-25. PubMed ID: 15273424
[TBL] [Abstract][Full Text] [Related]
23. [Effect of protease inhibitor on primary glomerulonephritis and the mechanism of the effect].
Onbe T; Makino H; Haramoto T; Wada J; Ogura T; Kumagai I; Murakami K; Fukushima M; Ota Z
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):753-9. PubMed ID: 1770635
[TBL] [Abstract][Full Text] [Related]
24. Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF.
Sanaka T; Fujimoto K; Niwayama J; Nishimura H; Naito T; Higuchi C; Akizawa T; Koide K; Koshikawa S
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S35-7. PubMed ID: 12612949
[TBL] [Abstract][Full Text] [Related]
25. [Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency].
Hottelart C; el Esper N; Achard JM; Pruna A; Fournier A
Nephrologie; 1999; 20(1):41-4. PubMed ID: 10081035
[TBL] [Abstract][Full Text] [Related]
26. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
27. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
[TBL] [Abstract][Full Text] [Related]
28. Strict blood-pressure control and progression of renal failure in children.
; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of prostaglandin E1 in the treatment of chronic pulmonary heart disease in the elderly people at the acute stage].
Huang CC; Xu M
Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):285-6. PubMed ID: 12536711
[TBL] [Abstract][Full Text] [Related]
30. Comparison of antiplatelet potency of sarpogrelate, aspirin, and beraprost in healthy volunteers according to in-vitro closure time.
Kim KM; Kim H; Chi HS; Park JS; Kim SB
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):262-5. PubMed ID: 20124989
[TBL] [Abstract][Full Text] [Related]
31. Effects of oral beraprost sodium, a prostaglandin I2 analogue, on endothelium dependent vasodilatation in the forearm of patients with coronary artery disease.
Ohata S; Ishibashi Y; Shimada T; Takahashi N; Sugamori T; Sakane T; Hirano Y; Oyake N; Murakami Y; Higami T
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):381-7. PubMed ID: 16620305
[TBL] [Abstract][Full Text] [Related]
32. [Is it justifiable to use antiplatelet drugs as a universal protection in patients with chronic glomerular damage?].
Duclos J
Rev Med Chil; 1993 Mar; 121(3):286-91. PubMed ID: 8248641
[TBL] [Abstract][Full Text] [Related]
33. The effects of proteinuria on urinary cystatin-C and glomerular filtration rate calculated by serum cystatin-C.
Kim JS; Kim MK; Lee JY; Han BG; Choi SO; Yang JW
Ren Fail; 2012; 34(6):676-84. PubMed ID: 22607020
[TBL] [Abstract][Full Text] [Related]
34. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
35. Effects of beraprost sodium, an oral prostaglandin i2 analog, on hemostatic factors and inflammation in chronic peritoneal dialysis patients.
Kim KM; Kim HW; Lee JH; Chang JW; Park JS; Kim SB
Perit Dial Int; 2009; 29(2):178-81. PubMed ID: 19293355
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure.
Tomita M; Sogabe H; Nakazato S; Nakatsuji S; Noto T; Hamada K; Kawachi H; Shimizu F; Matsuo M; Mutoh S
Nephrol Dial Transplant; 2005 Nov; 20(11):2358-67. PubMed ID: 16091375
[TBL] [Abstract][Full Text] [Related]
37. [Effects of salvianolate combined with alprostadil and reduced glutathione on progression of chronic renal failure in patients with chronic kidney diseases: a long-term randomized controlled trial].
Fu P; Huang XQ; Yuan AH; Yu G; Mei XB; Cui RL
Zhong Xi Yi Jie He Xue Bao; 2012 Jun; 10(6):641-6. PubMed ID: 22704412
[TBL] [Abstract][Full Text] [Related]
38. Effects of a supplemented hypoproteic diet in chronic kidney disease.
Mircescu G; Gârneaţă L; Stancu SH; Căpuşă C
J Ren Nutr; 2007 May; 17(3):179-88. PubMed ID: 17462550
[TBL] [Abstract][Full Text] [Related]
39. Renal effects of low dose aspirin in elderly patients.
Segal R; Lubart E; Leibovitz A; Iaina A; Caspi D
Isr Med Assoc J; 2006 Oct; 8(10):679-82. PubMed ID: 17125112
[TBL] [Abstract][Full Text] [Related]
40. [Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L?].
Zhang GH; Hou FF; Zhang X; Liu QF
Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):592-6. PubMed ID: 16194413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
